Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Intrinsic Value
The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 948.31 INR. Compared to the current market price of 3 246.4 INR, Torrent Pharmaceuticals Ltd is Overvalued by 40%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Torrent Pharmaceuticals Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Torrent Pharmaceuticals Ltd
Balance Sheet Decomposition
Torrent Pharmaceuticals Ltd
Current Assets | 58.8B |
Cash & Short-Term Investments | 14.8B |
Receivables | 17.9B |
Other Current Assets | 26.1B |
Non-Current Assets | 92.1B |
Long-Term Investments | 650m |
PP&E | 36.3B |
Intangibles | 46.7B |
Other Non-Current Assets | 8.4B |
Free Cash Flow Analysis
Torrent Pharmaceuticals Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Torrent Pharmaceuticals Ltd
Revenue
|
113B
INR
|
Cost of Revenue
|
-27.2B
INR
|
Gross Profit
|
85.8B
INR
|
Operating Expenses
|
-57.4B
INR
|
Operating Income
|
28.4B
INR
|
Other Expenses
|
-9.8B
INR
|
Net Income
|
18.6B
INR
|
TORNTPHARM Profitability Score
Profitability Due Diligence
Torrent Pharmaceuticals Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Torrent Pharmaceuticals Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
TORNTPHARM Solvency Score
Solvency Due Diligence
Torrent Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Torrent Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TORNTPHARM Price Targets Summary
Torrent Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 3 605.89 INR with a low forecast of 2 959.3 INR and a high forecast of 4 200 INR.
Dividends
Current shareholder yield for TORNTPHARM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 1 948.31 INR.
Compared to the current market price of 3 246.4 INR, Torrent Pharmaceuticals Ltd is Overvalued by 40%.